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cDNA Cloning and Primary Structure Analysis
of C1qRP, the Human C1q/MBL/SPA Receptor
That Mediates Enhanced Phagocytosis In Vitro
Ronald R. Nepomuceno,* Agnes H. Henschen-Edman,* SPA is a major component of the lung surfactant and
has been shown to interact with alveolar macrophagesWilson H. Burgess,† and Andrea J. Tenner*
*Department of Molecular Biology and Biochemistry and alveolar type II cells to enhance endocytosis of
phospholipids (Wright et al., 1987). In addition, we haveUniversity of California, Irvine
Irvine, California 92697 previously shown that, like C1q, MBL and SPA can func-
tion to enhance phagocytosis of immunoglobulin G†American Red Cross
J. H. Holland Laboratory (IgG)- or complement-opsonized particles by human
monocytes (Tenner et al., 1989, 1995; Bobak et al., 1987,Rockville, Maryland 20855
1988a). It is known that the collagen-like fragment of C1q
(C1q-CLF) is the region of the molecule that mediates
enhanced phagocytosis, since this response can onlySummary
be triggered by the pepsin-resistant fragment, and not
by the pepsin-sensitive, collagenase-resistant frag-The complement protein C1q, mannose-binding lectin
ments (Bobak et al., 1987). MBL and SPA also contain(MBL), and pulmonary surfactant protein A (SPA) are
a collagen-like domain, suggesting that some regionstructurally similar molecules that enhance phago-
within this structural domain is responsible for triggeringcytic function in vitro. Monoclonal antibodies R3 and
the enhanced phagocytosis, presumably by interactingR139, which inhibit the enhancement triggered by
with a common cellular receptor. As evidence of thisthese three ligands, were used to purify a 126,000 Mr
hypothesis, we have previously shown that the enhance-cell surface protein designated C1qRP. Amino acid se-
ment of phagocytosis triggered by each of these threequence was obtained and the corresponding cDNA
proteins can be inhibited by the monoclonal antibodieswas cloned. C1qRP is a novel type I membrane protein
R139 and R3 (Guan et al., 1991, 1994; Tenner et al.,with the following putative structural elements: a
1995; Ruiz and Tenner, 1996, Mol. Immunol., abstract),C-type carbohydrate recognition domain, five EGF-
indicating that the antigen recognized by these antibod-like domains, a transmembrane domain, and a short
ies is a critical, functional component of a receptorcytoplasmic tail. All peptides identified by amino acid
shared by C1q, MBL, and SPA. R139 and R3 bind tosequencing are encoded by the cDNA. Additionally,
a 126,000 Mr (reduced) glycoprotein that is highlyan anti-peptide antiserum was generated, which is
expressed on the surfaces of phagocytic cells suchreactive with C1qRP. The data indicate that the cloned
as monocytes/macrophages, neutrophils, endothelialcDNA encodes the receptor that plays a role in C1q/
cells, and microglia (rat), but not on B or T lymphoblas-MBL/SPA-mediated removal or destruction of patho-
toid cells (Korotzer et al., 1995; Lozada et al., 1995; Guangens and immune complexes by phagocytosis.
et al., 1994). Since these antibodies were first described
(Guan et al., 1991) as recognizing the C1q receptor that
modulates monocyte phagocytosis, the 126,000 Mr pro-Introduction
tein was designated C1qRP. To elucidate further the role
C1qRP plays in regulating phagocytosis, we have clonedThe complement component C1q, mannose-binding
the cDNA encoding this receptor protein, deduced thelectin (MBL), and pulmonary surfactant protein A (SPA)
amino acid sequence, and, based on similarity and motifare part of a family of host defense proteins that have
searches, proposed a domain structure.strikingly similar macromolecular structures, which in-
clude a collagen-like region contiguous with a globular
domain (Drickamer et al., 1986; Hoppe and Reid, 1994). Results
C1q is composed of covalently linked subunits of three
distinct polypeptide chains, each with an N-terminal col- C1qRP Purification and Amino Acid Sequencing
To gain a further understanding of how C1qRP functionslagen-like region, while MBL and SPA are homopoly-
mers with similar N-terminal collagen helices but with to enhance phagocytosis triggered by its three known
ligands, the structure of the receptor is required. At-the distinctive C-type carbohydrate recognition do-
mains (CRDs) in the C-terminal half of the proteins. In tempts to screen a cDNA expression library using the
inhibiting monoclonal antibodies were unsuccessful,addition to this structural homology, the proteins share
functional homology. C1q is the recognition subunit of probably owing to the poor reactivity of these antibodies
with the antigen in its reduced form (see Figure 5; Guanthe C1 component of the classical complement pathway
(CCP) in that it binds to the Fc region of antibodies in et al., 1994). The polyclonal antibodies QR1 and 710,
while reactive against C1qRP in both its reduced andimmune complexes, as well as a variety of nonimmuno-
globulin substances, and can initiate the CCP. MBL, nonreduced forms (see Figure 5; data not shown), are
not monospecific for the receptor and therefore werealso known as mannose-binding protein or mannan-
binding protein, is a mammalian lectin that, as part of unsuitable for library screening. Consequently, the re-
ceptor protein was isolated to obtain amino acid se-the innate humoral immune system, can identify foreign
pathogens by detecting specific carbohydrate struc- quence data that could be used to design degenerate
oligonucleotide probes, polymerase chain reactiontures uniquely present on microorganisms and subse-
quently initiate the CCP (reviewed by Ezekowitz, 1991). (PCR) primers, or both. Purified 710 or R3 antibodies
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SDS–PAGE gels and subjected to either trypsin or endo-
proteinase Lys-C digestion and subsequent peptide
fractionation by reverse-phase high pressure liquid
chromatography (HPLC) and sequencing. In another ap-
proach, both the 126,000 Mr and 90,000 Mr proteins were
transferred to nitrocellulose for N-terminal sequencing,
as well as peptide sequencing of HPLC-separated pep-
tides from endoproteinase Lys-C digests. The se-
quenced peptides are summarized in Table 1. One of
the sequenced peptides, FWIGLQREK, is conserved
(Table 2) amongcertain membrane receptors that modu-
late endocytosis, including the human and murine man-
nose macrophage receptor (Ezekowitz et al., 1990),
chicken hepatic lectin (Drickamer et al., 1986), and the
b subunit of human fibronectin receptor (Argraves et al.,
1987), which is consistent with the fact that C1qRP playsFigure 1. Affinity-Purified C1qRP
a role in modulating monocyte phagocytosis.Immobilized purified monoclonal antibody R3 (IgM) was used to
affinity purify the receptor antigen from U937 detergent extracts.
Eluted protein was concentrated and subjected to SDS–PAGE
Cloning of C1qRP cDNA(7.5%) under reducing conditions, followed by Coomassie blue
staining (left). Mature 126,000 Mr C1qRP is indicated by the arrow. A somewhat atypical trypsin cleavage after a tyrosine
Breakdown fragments are indicated by the arrowhead and asterisk. residue of the purified protein resulted in the peptide
Molecular weight standards are shown in the right lane. 202 (Table 1). The beginning of this peptide overlaps
the last seven amino acids of peptide 186, resulting in
a 44 residue amino acid sequence. Degenerate oligonu-were used to affinity purify C1qRP from NP-40 detergent
extracts of U937 cells. The eluted material was concen- cleotide primers were used to amplify, by reverse tran-
scription–PCR (RT–PCR), a 101 bp cDNA (PCR1) frag-trated by ultrafiltration, precipitated with trichloroacetic
acid, and then separated by SDS–polyacrylamide gel ment from U937 mRNA corresponding to 34 amino acids
of the overlapping peptide sequences (Figure 2). A spe-electrophoresis (SDS–PAGE) under reducing condi-
tions. A typical Coomassie blue–stained gel of R3-puri- cific primer based on this 101 bp cDNA was used in
combination with another degenerate primer corre-fied material is shown in Figure 1. The mature protein
migrates with an apparent molecular weight of 126,000. sponding to the N-terminus of the protein, starting at
the second amino acid, toamplify a 570 bp cDNA (PCR2)Two additional bands with apparent molecular weights
of 90,000 and 60,000 were variably seen and are most of C1qRP (Figure 2). This 570 bp PCR2 fragment was
then used to screen a U937 lgt11 cDNA library. Onelikely breakdown products resulting from thepurification
procedure, since both fragments are also reactive with phage was identified (clone 15), which contained a 1458
bp insert that overlapped PCR2 by 165 bp. The insertanti-C1qRP antibodies (see Figure 5). Additionally, the
90,000 Mr fragment has the identical N-terminus, as well from clone 15 was used to rescreen the U937 lgt11
cDNA library, and four additional distinct phage insertsas some identical internal peptides, as the mature pro-
tein. The 126,000 Mr receptor protein was excised from were identified (Figure 2). Clone 3 contains a 1832 bp
Table 1. C1qRP Peptides Determined by Amino Acid Sequencing
Peptide Identificationa Sequenceb
N-terminus 22 VGADTEAVVXXGTATYRIHXKL















a Amino acid number of residue in the first position.
b Discrepancies from deduced amino acid sequence are indicated by bold letters.
c Peptide sequence (underlined) used to generate the anti-peptide antiserum.
d Peptide sequences identified by reexamination of data derived from peptide mixtures.
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Table 2. Peptide 93 Data Base Matches reexamined and three new peptide sequences were
found (Table 1), which further confirm the predicted se-Hu C1qRP F W I G L Q R E
quence.Hu fibronectin receptor (b1) CD29 F W I G L
Hu macrophage mannose receptor F W I G L F R
Mu NKR-P1 11 F W I G L — R Sequence Data Analysis of C1qRP
Mu NKR-P1 12 F W I G L — R Similarity searches of the protein and nucleotide data
Mu NKR-P1 14 F W I G L
bases indicate that C1qRP is a novel protein, the struc-Mu macrophage mannose R F W I G M F R
tural domains of which are shown in Figure 3B. After aCh hepatic lectin F W I G L T D E
21 amino acid signal peptide, there is a 156 amino acidCh tenascin F W I G L
Su SPC3 protein F W I G L region resembling a C-type CRD containing 7 of the
Hy HYDTYRKIN 1 F W I G L 18 nearly “invariant” CRD residues (Drickamer, 1988),
including the four cysteine residues that are involved inAbbreviations are as follows: Hu, human; Mu, murine; Ch, chicken;
Su, sea urchin; Hy, Hydra. disulfide bonds within the domain. As Figure 4A illus-
trates, insertion of several gaps is required to obtain
alignment of this domain of C1qRP with various other
insert that overlaps clone 15 by 449 bp. To obtain the proteins with the defined CRD. It remains to be deter-
59 end of the cDNA, we used specific primers based on mined whether this CRD-like domain in C1qRP retains
sequences derived from PCR2 in 59 rapid amplification a carbohydrate binding function. C1qRP contains five
of cDNA ends (RACE) PCR reactions to amplify a 297 epidermal growth factor (EGF)-like domains, the last
bp product (PCR3), which overlaps PCR2 by 83 bp. The three of which contain an asparagine hydroxylation mo-
PCR products and clones 15 and 3 were sequenced in tif consistent with calcium-binding EGF domains (Rees
their entirety on both strands, and the 3460 bp of total et al., 1988). Although C1qRP is a novel protein, data
cDNA was translated. The open reading frame of the base searches show strong homology to the other di-
cDNA encodes a 652 amino acid precursor protein. verse, nonrelated extracellular proteins, including fibril-
Based on the sequencing of its N-terminus, the mature lin, thrombomodulin, and fibulin owing to their EGF do-
polypeptide is 631 amino acids in length and has a mains (Knott et al., 1996; Argraves et al., 1990; Hunter
predicted molecular mass of 66,495 Da and a pI of 5.24 and Komives, 1995). Alignments of the C1qRP EGF-like
based on amino acid content alone. The amino terminal domains with some of these domains from other pro-
sequence starting at amino acid 22, as well as all of teins are shown in Figures 4B and 4C. Other notable
the sequenced internal regions, are found within the features of this novel receptor include a single putative
predicted amino acid sequence (Table 1; underlined in N-linked glycosylation site at residue Asn-325 (bold in
Figure 3A) indicating that this cDNA corresponds to the Figure 3A) and a single 25 amino acid putative trans-
isolated C1qRP protein. Although a phage clone con- membrane domain (double underlined in Figure 3A), as
taining a poly(A) tail has not yet been found, the stop determined by the TMpred program, the algorithm of
codon for the protein is located only 54 bp downstream which is based on the statistical analysis of TMbase, a
of the most C-terminal peptide determined by amino data base of naturally occurring transmembrane pro-
acid sequencing, and this nucleotide sequence, like the teins (Hofmann and Stoffel, 1993, Biol. Chem. Hoppe-
entire cDNA, has been verified by sequencing three Seyler, abstract). At the C-terminus, there is a short, 47
times on both strands of the cloned DNA. In addition, amino acid putative cytoplasmic tail. Within the cyto-
there is a second, in-frame UGA stop codon two codons plasmic tail, there is a cytoplasmic anchor composed
downstream of the initial stop codon. There are also of basic amino acids and a tyrosine residue at position
several stop codons within 195 bp of the last sequenced Tyr-644 that is part of a consensus motif, R/KX2–3D/
peptide in each of the reading frames, further suggesting EX2–3Y, that is recognized by tyrosine kinases (Patschin-
that the end of the coding region for this polypeptide sky et al., 1982).
has been localized. Once the cDNA was translated and
the amino acid sequence deduced, amino acid se- Anti-Peptide Antibody Reacts with Purified C1qRP
quence data from HPLC peaks containing peptide mix- As further evidence that the cloned cDNA corresponds
to C1qRP, a synthetic peptide, VGGGEDTPYSN, basedtures derived from the trypsin digest of C1qRP were
Figure 2. C1qRP PCR and lgt11 Clones
The positions of the three PCR fragments and isolated lgt11 clones
are shown.After PCR1, PCR2, and clone 15 were sequenced, clones
2, 3, 7, and 16 were sequenced at the 59 and 39 ends to determine
their positions. Clone 3 was then sequenced in its entirety. PCR3
was generated by the 59 RACE PCR method.
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Figure 3. cDNA and Deduced Amino Acid Sequence of C1qRP and
Diagram of Its Structural Domains
(A) C1qRP cDNA nucleotides are numbered with the first base of the
initiator methionine as 11. Amino acid 1 is the initiator methionine.
The underlined sequences are the N-terminus of the mature protein
and internal peptide residues that were determined by amino acid
sequencing (except for italicized residues). The single putative N-glycosylation site is in bold starting at position Asn-325. The transmembrane
domain is double underlined.
(B) The schematic diagram illustrates the domains contained within C1qRP, which include a 21 amino acid signal peptide (SP) and a C-type
CRD at the N-terminus, five EGF-like domains (numbered), including three calcium-binding (cb) EGF domains, and a single transmembrane
(TM) domain. The putative N-linked glycosylation site is indicated within the second EGF domain.
on an internal peptide sequence found in separate di- form and its 90,000 Mr breakdown product) in both their
reduced and mobility-shifted nonreduced forms, andgests (Table 1), was used to generate a rabbit polyclonal
anti-peptide antiserum. Western blot analysis of purified that the peptide, which is encoded by the cloned cDNA,
was sequenced from three separate digests using differ-C1qRP transferredto nitrocellulose showed that the anti-
peptide antiserum reacts with the 126,000 Mr receptor ent protocols to generate the fragments, is correlative
evidence that the cDNA corresponds to C1qRP.in both its reduced and nonreduced forms (Figure 5).
Interestingly, the anti-peptideantiserum also recognizes
the 90,000 Mr breakdown product, but does not recog- Southern and Northern Blot Analysis
To begin to characterize the genomic organization andnize the smaller 60,000 Mr product, indicating that this
latter fragment does not contain the N-terminus of the expression of C1qRP, we carried out Southern and
Northern blotting using a probe based on the clone 15protein. The fact that the anti-peptide antiserum reacts
with two forms of the receptor (the 126,000 Mr full-length insert, which corresponds to 486 amino acids (74.5%)
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Figure 4. Alignments of C1qRP CRD and
EGF-like Domains
(A) Alignment of the putative C1qRP CRD with
the similar domains of various proteins with
reference to the invariant residues of C-type
lectins. Note that not all of the “invariant” resi-
dues are conserved and the amino acids
present in at least four of the domains are
shown below as the consensus. Numbers in
parentheses denote the position of the first
amino acid in the respective sequence of
each protein. Sequences were obtained from
the Swiss-Prot data base with the follow-
ing accession numbers: human E-selectin,
P16581; Trimeresurus flavoviridis factor IX/
X–binding protein B chain, P23806; rat he-
patic lectin 2, P08290; rat pulmonary surfac-
tant protein D, P35248; human macrophage
mannose receptor, P22897.
(B and C) Alignments of C1qRP amino acid
sequences with domains of various proteins
homologous to EGF. Sequences are grouped
as non–calcium binding (B) and calcium-
binding EGF-like domains (C). Conserved
cysteine residues are in bold, as are residues
characteristic of the calcium-binding EGF do-
mains. The underlined regions are the hy-
droxylation sites with the consensus se-
quence CXD/NXXXXF/YXCXC. The putative
b-hydroxyasparagine is marked by the aster-
isk. Sequences were obtained from the
Swiss-Prot data base.
of the coding region, beginning at position P158. Human Discussion
genomic DNA isolated from whole blood was digested
with restriction enzymes and separated by agarose gel We report here the cDNA and deduced amino acid se-
electrophoresis. The DNA was transferred to a nylon quence for C1qRP, a novel cell surface transmembrane
membrane and was hybridized to a C1qRP probe gener- glycoprotein that is the receptor or a receptor compo-
ated by the random priming method. The single band nent that mediates an activation signal induced by liga-
hybridizing in three of the four digests indicates that the tion of C1q, MBL, or SPA and that results in an enhanced
gene for C1qRP is present as a single copy in the human phagocytotic capacity of the ligated cell. Homology
genome (Figure 6). The two bands present in the EcoRI searches have detected the presence of a consensus
digests may be due to the presence of this restriction motif that is found in some other cell surface proteins
site(s) within an intron, since the clone 15 cDNA insert that modulate endocytosis (Table 2), as well as five EGF
does not contain an EcoRI site. domains, a C-type CRD, a transmembrane domain, and
To determine the message size of C1qRP, mRNA was a tyrosine phosphorylation motif. Thus, this molecule
isolated from U937 cells, separated by agarose gel elec- has the necessary molecular components needed to
transduce a signal and can be postulated to be a criticaltrophoresis, and transferred to a nylon membrane. Using
a probe generated as in the Southern blot, the messen- receptor of the innate immune system (Manz-Keinke et
al., 1992; Epstein et al., 1996; Jensenius, 1995; Sum-ger RNA for C1qRP was found to be a single species of
6.7 kb (Figure 7). In contrast, the C1qRP probe did not merfield et al., 1995; Super et al., 1989), as well as func-
tioning in immune complex clearance (van Iwaarden ethybridize to mRNA isolated from CEM cells. This cell
type–specific mRNA expression is consistent with our al., 1990; Daha et al., 1988; Van den Dobbelsteen et al.,
1996; Veerhuis et al., 1985), clearance of cellular debrisprevious report showing that C1qRP is not expressed
on the surface of CEM cells, in contrast with U937 cells (Jiang et al., 1992; Kovacsovics et al., 1985), or both.
While the predicted molecular mass of the polypeptide,(Guan et al., 1994).
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Figure 5. Anti-Peptide Antibody Recognizes C1qRP
R3-purified C1qRP was subjected to SDS–PAGE under nonreducing
(lanes 1–3) and reducing (lanes 4–6) conditions and then transferred
Figure 7. Northern Blot Analysis of mRNA for C1qRPto nitrocellulose. The blot was probed with monoclonal antibody
Messenger RNA was separated by agarose gel electrophoresis andR139 (lanes 1 and 4), polyclonal anti-peptide antiserum (lanes 2
transferred to nylon. The blot on the left was probed for C1qRP andand 5), and polyclonal anti-C1qRP antiserum QR1 (lanes 3 and 6).
the blot on the right was probed for GAPDH as a control for RNAIsotype- and species-matched antibodies were used as probes in
levels. Positions of the 0.24–9.49 kb RNA ladder are indicated onparallel and resulted in no reactivity similar to lane 4 (data not
the far right.shown). Arrows indicate the intact receptor, whereas breakdown
fragments are indicated by the arrowheads and asterisks. Positions
of the molecular weight standards are indicated on the left.
Researchers in other laboratories have identified C1q-
binding proteins with apparent molecular weights differ-66,495 Da, is much lower than the 126,000 correspond-
ent from the 126,000 Mr C1qRP. A molecule of 33,000ing to the relative migration seen with SDS–PAGE, pre-
Mr has been shown to bind to the globular heads ofliminary experiments suggest the presence of an
C1q (Ghebrehiwet et al., 1994), but has recently beenN-linked oligosaccharide and a high degree of O-linked
localized primarily to the lumen of intracellular vesiclesglycosylation. In addition, it is knownthat neuraminidase
in Raji cells, a B lymphoblastoid cell line (Van den Bergtreatment resulted in a significant decrease in the appar-
et al., 1996, Mol. Immunol., abstract). Recent studies byent size of the molecule, consistent with a contribution
Lim and coworkers (1996) have shown that gC1qR (bothof carbohydrate to the migration pattern (Guan et al.,
recombinant and the native protein isolated from Raji1991). Finally, the protein has regions containing high
cells) also functions as a novel vitronectin-binding factorcontents of proline and charged residues that may con-
independent of C1q. The authors propose that this prop-tribute to extended conformations and anomalously
erty of gC1qR may allow the protein to participate inslow mobilities with SDS–PAGE (Guest et al., 1985).
certain immune functions, such as clearance and com-
plement inhibition, that may be associated with vitronec-
tin-containing complexes. However, the role, if any, that
this C1q/vitronectin-binding protein plays in phagocytic
function remains to be demonstrated.
Ghebrehiwet and colleagues, and later others, iso-
lated a 60,000 Mr C1q-binding protein that, like the
33,000 Mr protein, is expressed by Raji cells (Ghebrehi-
wet et al., 1984, 1988; Malhotra and Sim, 1989), in
contrast with C1qRP (Guan et al., 1994). This 60,000
Mr protein, designated cC1qR, binds to C1q through
its collagen-like region (Peerschke and Ghebrehiwet,
1987), and protein sequencing has shown significant
homology between this molecule and calreticulin (Mal-
hotra et al., 1993), a calcium-binding protein found in
several cellular compartments with many postulated
functions (Dedhar, 1994; Wada et al., 1995).Functionally,
cC1qR has been demonstrated to be involved in the
adherence of fibroblasts and platelets to C1q-coated
surfaces (Bordin et al., 1990; Peerschke and Ghebrehi-
wet, 1990). Monoclonal antibodies that react with this
Figure 6. Southern Blot Analysis of Human Genomic DNA for C1qRP calreticulin-like cC1qR block the C1q-mediated induc-
DNA was digested with BamHI, EcoRI, HindIII, and PstI. After aga- tion of aIIb/b3 integrin on platelets (Peerschke et al.,
rose gel electrophoresis and transfer, the DNA was hybridized to a
1993) and mimic the ability of C1q to inhibit collagen-32P-labeled probe generated by random priming of the lgt11 clone
induced aggregation of platelets, although the collagen15 insert. Positions of size markers (in base pairs) are indicated at
the far left. receptor mediating platelet adhesion differs from the
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“C1qR” of 60,000 Mr (Peerschke and Ghebrehiwet, establish whether C1qRP mediates this response in PMN
and endothelial cells. The molecular events involved in,1990). cC1qR is also reported to be present on the sur-
faces of cells of myeloid origin. However, no antibody and regulating, the phagocytic process have not been
completely elucidated, although it is clear that morereactive with this 60,000 Mr protein has been shown
to inhibit C1q-induced enhancement of phagocytosis. than one pathway can be evoked (Gresham et al., 1988,
1989; Brown, 1986; Pommier et al., 1983). For example,Conversely, the monoclonal antibodies that recognize
C1qRP are able to inhibit a myeloid cell response (en- a monoclonal antibody (B6H12) generated by Brown
and colleagues directed against an integrin-associatedhanced monocyte phagocytosis), indicating a functional
role for C1qRP in this cell type (Tenner et al., 1995; Guan protein (Brown et al., 1990) has been shown to block
the enhancement of phagocytosis induced by many, butet al., 1991, 1994).
C1q has also been reported to bind to other cell types not all, extracellular matrix proteins containing the Arg-
Gly-Asp sequence (Gresham et al., 1989). B6H12 doesand trigger a variety of cell-specific biological re-
sponses. For example, C1q stimulates oxidative metab- not block the C1q-mediated enhancement of phagocy-
tosis, whereas the antibody to C1qRP inhibits C1q-,olism in neutrophils (Hamada et al., 1988; Tenner and
Cooper, 1980), eosinophils (Hamada and Greene, 1987), MBL-, and SPA-mediated, but not fibronectin-mediated,
enhancement of phagocytosis (Guan et al., 1991; Tennerand vascular smooth muscle cells (Shingu et al., 1989),
enhances antibody-dependent cell cytotoxicity (Leu et et al., 1995; Ruiz and Tenner, 1996, Mol. Immunol., ab-
stract).al., 1989; Bobak et al., 1988b; Hamada and Greene,
1987), and stimulates antibody production by B cells The possibility of regulating the phagocytic capacity
of myeloid cells could be extremely valuable as a pro-(Young et al., 1991; Daha et al., 1990; Tenner et al.,
1987, Fed. Proc., abstract). In addition, C1q stimulates phylactic treatment for individuals at risk for infection,
such as individuals with genetic immunodeficiencies orcalcium-activated K1 channels and initiates chemotaxis
in mouse fibroblasts (Oiki and Okada, 1988), and en- infected with HIV, patients undergoing cancer chemo-
therapy, or patients undergoing high risk surgery. Ourhances uptake of Trypanosoma cruzi trypomastigotes
by human fibroblasts (Rimoldi et al., 1989). Interestingly, recent in vitro findings that proinflammatory cytokines
are not induced by C1q suggest that monocyte activa-in contrast with C1q, neither SPA or MBL stimulates
O22 production by polymorphonuclear leukocytes (PMN) tion by C1q is selective (Jasinskiene et al., submitted).
Similarly, Soell et al. (1995) and Geertsma et al. (1994)(Goodman and Tenner, 1992). In addition, repeated ex-
periments have shown that the monoclonal antibodies have independently demonstrated that neither MBL nor
SPA, both of which are ligands for C1qRP, triggers re-that inhibit C1q-mediated phagocytic function do not
inhibit C1q-mediated O22 production by PMN (Guan et lease of proinflammatory cytokines. Thus, activation of
monocytes/macrophages via this receptor may be moreal., 1994). These data, together with studies mapping
the region of the C1q collagen-like domain that triggers beneficial than other pharmacologic agents that trigger
proinflammatory cytokine release (Testerman et al.,O22 production (Ruiz et al., 1995), suggest that the neu-
trophil C1q receptor that triggers O22 production, which 1995). For example, TNFa enhances HIV expression,
and thus induction of this proinflammatory cytokine maywe designate C1qRO22, differs in some way from the
C1q receptor that enhances phagocytosis, C1qRP. Both be detrimental rather than protective in HIV-infected in-
dividuals. One compound with immunoregulatory prop-the monoclonal antibodies and cDNA cloned here are
being used to determine the cell type– (R. R. N. and erties similar to C1q, in that it enhances anti-microbial
activity without an inflammatory response, is a glucoseand A. J. T., unpublished data) and tissue type–specific
expression of C1qRP and investigate the relationship polymer, PGG-glucan, which has shown significant effi-
cacy in phase I/II trials in reducing postsurgery infec-between C1qRP and C1qRO22 and othercell surface C1q-
binding proteins. It is important to note that there is tions (Poutslaka et al., 1993; Babineau et al., 1994). While
very little is known about the receptor(s) or the signalingalso substantial evidence for additional SPA cell surface
receptors (Tino and Wright, 1996; McIntosh et al., 1996; mechanisms involved in the PGG-glucan system, the
molecular probes generated here should aid in the char-Tenner et al., 1989; Pison et al., 1992; Chroneos and
Shepherd, 1995). This diversity of receptors should be acterization of the biochemical pathways involved in the
C1q/MBL/SPA receptor system. This information mayuseful in the design of specific therapeutic modulators
of the functions mediated by the receptors. provide the basis for rational manipulationof this system
in a clinically advantageous manner.Phagocytosis is a major host defense mechanism by
which potentially deleterious material (both pathogenic
Experimental Proceduresorganisms and cellular debris) is cleared from circulation
and tissue and made accessible to inactivation. The
Reagents and Cell Culturephagocytic capacity or potential of a cell can be modu-
The ImmunoPure IgM purification kit, ReactiGel (63) Support, and
lated by cytokines that trigger cellular differentiation NP-40 were purchased from the Pierce Chemical Co. (Rockford,
(Gresham et al., 1986; Sampson et al., 1991) or by other IL). Protein A–Sepharose and CNBr–Sepharose were obtained from
activation ligands. This activation is probably relevant Pharmacia Biotech Inc. (Piscataway, NJ). TPCK–trypsin was pur-
chased from Worthington (Freehold, NJ). The RPMI 1640 medium,at sites of inflammation where MBL, SPA, C1q, and/or
Dulbecco’s modified Eagle’s medium, SuperScript preamplificationother regulatory molecules may accumulate and en-
system for first strand cDNA synthesis kit, DNAZOL reagent, Rad-hance the phagocytic capacity of acute inflammatory
Prime DNA labeling system, herring sperm DNA, 0.24–9.5 kb RNA
cells. C1q has also been shown to enhance the phago- ladder, 1 kb DNA ladder, and the 59 RACE system (for rapid amplifi-
cytic capacity of neutrophils (Ohkuro et al., 1994) and cation of cDNA ends), Version 2.0 were obtained from GIBCO BRL
endothelial cells (Ryan et al., 1989), both of which also (Grand Island, NY). Except where noted otherwise, all other reagents
were purchased in the highest quality from Sigma Chemical Co. (St.express surface C1qRP. Further studies are needed to
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Louis, MO). The human histiocytic cell line, U937, was grown in Coomassie blue in 40% methanol, 1% acetic acid and then de-
stained with several changes of 50% methanol. After several washessuspension at 378C in RPMI 1640 medium containing 10% supple-
mented bovine calf serum (Hyclone, Logan, UT) and 10 mM HEPES with water, the 126,000 Mr and 90,000 Mr bands were cut from the
PVDF and individually subjected to N-terminal sequencing using an(pH 7.4). The human acute lymphoblastic leukemia cell line, CEM,
was grown in Dulbecco’s modified Eagle’s medium supplemented Applied Biosystems model 473A amino acid sequencer. Alterna-
tively, preparations of R3-purified protein were transferred to Pro-with 10% FCS (Hyclone).
tran nitrocellulose (Schleicher & Schuell) as described above. The
membrane was then stained for 10 min in 0.5% Ponceau S in 1%
Antibodies acetic acid and then destained with 0.1 mM acetic acid. Both the
The R139 and R3 monoclonal antibodies and 710 polyclonal antise- 126,000 Mr and 90,000 Mr bands were cut from the nitrocellulose
rum were generated by immunization with C1q-CLF-binding pro- and individually subjected to internal peptide sequencing after en-
teins isolated from U937 cell extracts as previously described (Guan doproteinase Lys-C digestion and separation of peptides by HPLC.
et al., 1994). Polyclonal antiserum QR1 was generated by immuniza-
tion of a rabbit with the 126,000 Mr C1qRP band extracted from
agarose gels after separation by electrophoresis using the ProSieve PCR and Library Screening
A trypsin cleavage in the protein after a tyrosine residue allowed forGel System (FMC BioProducts, Rockland, ME) according to the
instructions of the manufacturer. The anti-peptide polyclonal antise- the overlap of peptides 186 and 202, which includes the sequence
GGPGQVTYTTPFQTTSSSLEAVPFASAANVACGE. Based on this se-rum was generated by immunization with a mixture of two peptides,
VGGGEDTPYSN and VGGGEDTPYSNK (to allow conjugation at the quence, two degenerate primers were synthesized and used for
RT–PCR using cDNA generated with the SuperScript preamplifica-C-terminal amino acid), conjugated to keyhole limpet hemocyanin
using glutaraldehyde as the cross-linker (Maloy et al., 1991). Purified tion system for first strand cDNA synthesis kit according to the
instructions of the manufacturer from mRNA isolated from U937R3 IgM was obtained from ascites fluid using the ImmunoPure IgM
purification kit according to the instructions of the manufacturer. cells as template. The forward oligonucleotide was 59-GG(agct)GG(a
gct)CC(agct)GG(agct)CA(ag)GT(agct)AC-39 and the reverse was710 IgG was purified by affinity chromatography using protein
A–Sepharose as described previously (Andrew and Titus, 1991). 59-TC(agct)CC(agct)GC(agct)GC(agct)AC(ag)TT(agct)GC-39. The PCR
product of 101 bp was isolated on a 12% polyacrylamide gel (Sam-
brook et al., 1989), cloned into the pGEM-T vector (Promega, Madi-
Protein Isolation and Amino Acid Sequencing son, WI), and sequenced using the Sequenase Quick-Denature plas-
Purified 710 IgG was coupled to CNBr-activated Sepharose 4B, and mid sequencing kit (United States Biochemical, Cleveland, OH) to
purified R3 IgM was coupled to ReactiGel (63) according to the confirm that it encoded the expected peptide. A specific primer
directions of the manufacturer. For a single preparation, approxi- based on this PCR product, 59-CAAGGAGGAACTGGTGGTCTGG-39,
mately 6 3 108 U937 cells were washed once in ice-cold RPMI 1640 and a degenerate primer based on the sequenced N-terminus start-
and then once in ice-cold PBS (pH 7.4). The pelleted cells were ing at the second amino acid, 59-GGIGCIGA(tc)ACIGA(ag)GC-39,
resuspended to a concentration of 108 cells per milliliter in extraction were used to amplify by RT–PCR the cDNA corresponding to the
buffer (10 mM triethanolamine [pH 7.4], 1 mM CaCl2, 1 mM MgCl2, N-terminus of the mature protein from U937 cDNA. This 570 bp PCR
0.15 M NaCl, 0.3% NP-40, 1 mg/ml pepstatin, 5 mg/ml leupeptin, product was also cloned into the pGEM-T vector and sequenced
1 mg/ml aprotinin, and 1 mM phenylmethylsulfonyl fluoride [PMSF]). and was then used to screen a lgt11 U937 cDNA library (Clontech,
After a 1 hr incubation on ice with occasional mixing, the cell extract Palo Alto, CA) using conventional techniques. The 1458 bp EcoRI
was centrifuged at 48C at 12,000 3 g for 10 min to pellet insoluble insert from a positive phage (clone 15) was cloned into pBluescriptII
material. The extract was precleared by incubation for 1 hr on ice KS(1) (Stratagene, La Jolla, CA), sequenced, and then used to re-
with 40% (v/v) packed Sepharose CL-4B. The Sepharose was re- screen the U937 lgt11 cDNA library. Four new positive phage were
moved, the lysate was diluted6-fold with 20 mM Tris (pH 7.4), 0.15 M isolated, and both ends of each insert were sequenced using the
NaCl, 1 mM PMSF to dilute the NP-40 to a final concentration of fmol DNA Sequencing System (Promega) to determine their position
0.05%, and it was then applied to the antibody column at 48C. After relative to clone 15. Clone 3, which contains a 1832 bp insert that
washing with 10 column volumes of 20 mM Tris (pH 7.4), 0.5 M NaCl, extends the farthest downstream, was then cloned into pBluescriptII
0.05% NP-40, 1 mM PMSF, the bound antigen was eluted with 0.1 M KS(1) and sequenced in its entirety. To obtain the 59 region of the
glycine (pH 2.4), 0.5 M NaCl, 0.5% NP-40, 1 mM PMSF. To neutralize cDNA, the 59 RACE system was used according to the instructions
the pH of the eluted material, 1 M Tris (pH 10.5) was added to a of the manufacturer. The gene-specific primer 1 (GSP1) used
final concentration of 50 mM. C1qRP-containing fractions were to generate the cDNA from 1.75 mg of U937 total RNA was
pooled and concentrated by ultrafiltration using Centricon 30 con- 59-TTGGCCGCAGAGGCAAAGGGCA-39. The primary PCR reaction
centrators (Amicon Inc., Beverly, MA). The protein was then precipi- was done with the supplied 59 RACE Abridged Anchor Primer and
tated overnight on ice using trichloroacetic acid at a concentration a nested primer, GSP2, of the sequence 59-CAAGGAGGAACTGGTG
of 10%. After the precipitate was washed with ice-cold acetone and GTCTGG-39. The reaction product from this primary PCR was used
air dried, it was resuspended in 20 ml of Laemmli’s loading buffer as the template for a final PCR reaction using the supplied Abridged
(Laemmli, 1970), boiled for 5 min, and subjected to SDS–PAGE (7.5% Universal Amplification Primer and another nested primer, GSP3, of
acrylamide) under reducing conditions and in the presence of 0.1 the sequence 59-TGGGCCTCGGCAGCGCTCAGCT-39. The resulting
mM thioglycolic acid in the electrophoresis running buffer. In some 297 bp PCR product was cloned into the pGEM-T vector and se-
instances, the gels were stained directly with Coomassie blue and quenced. Complete sequencing of the phage clone inserts 3 and
the 126,000 Mr band was excised from the gel. Gel slices containing 15 was done using the Erase-a-Base System (Promega) and the
protein isolated from the 710 column weresubjected to endoprotein- Sequenase Quick-Denature plasmid sequencing kit (United States
ase Lys-C digestion, fractionation on a Vydac C-18 column, and Biochemical, Arlington Heights, IL) to obtain unambiguous overlap-
subsequent amino acid sequencing on an Applied Biosystems se- ping readings from both strands. Computer analysis of the sequenc-
quencer, resulting in peptide sequences 93 and 113 (Table 1). Gel ing data was done using the Lasergene DNASTAR for Windows
slices containing receptor isolated by R3 affinity chromatography software.
were digested in situ with TPCK–trypsin using the procedure of
Ward et al. (1990). After isolation of the peptide fragments using a
C4 reverse-phase column (Vydac, Hesperia, CA), the peptide-con- Sequence Data Analysis
The National Center of Biotechnology Information (NCBI) electronictaining peaks were subjected to protein sequencing on a Hewlett-
Packard protein sequencing system, model G1005A, with an on- mail server BLAST was used to search for homologous sequences
in the nonredundant compilation of the protein data bases. Motifline analyzer of the amino acid derivatives. Other preparations of
the protein after SDS–PAGE were electrophoretically transferred to searches were done using the Motifs program of the GCG computer
package, Version 8 (Madison, WI), and the transmembrane domainWestran PVDF (Schleicher & Schuell, Keene, NH) as described by
Towbin et al. (1979) for 2–3 hr, with the addition of 0.2% SDS to the was predicted using the TMpred program (Hofmann and Stoffel,
1993, Biol. Chem. Hoppe-Seyler, abstract). Sequence alignmentstransfer buffer. The membrane was stained for 1 min with 0.1%
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were done using the Megalign program of the Lasergene DNASTAR Modulation of FcR function by complement: subcomponent C1q
enhances the phagocytosis of IgG-opsonized targets by humanfor Windows software package.
monocytes and culture-derived macrophages. J. Immunol. 138,
1150–1156.Western Blot Analysis
After R3 affinity-purified C1qRP was transferred to nitrocellulose as Bobak, D.A., Frank, M.M., and Tenner, A.J. (1988a). C1q acts syner-
described above, the membrane was blocked with 3% nonfat dry gistically with phorbol dibutyrate to activate CR1-mediated phago-
milk in Tris-buffered saline containing 0.05% Tween 20 (TBST). R139 cytosis by human mononuclear phagocytes. Eur. J. Immunol. 18,
and control IgG2b were diluted to 5 mg/ml and the rabbit antisera 2001–2007.
were diluted 1:1000 in the blocking buffer. Bound antibodies were
Bobak, D.A., Washburn, R.G., and Frank, M.M. (1988b). C1q en-
detected using peroxidase-conjugated anti–mouse IgG or anti–
hances the phagocytosis of cryptococcus neoformans blastospores
rabbit IgG, and the peroxidase was detected using 4-chloro-1-naph-
by human monocytes. J. Immunol. 141, 592–597.
thol (Bio-Rad Laboratories, Hercules, CA).
Bordin, S., Ghebrehiwet, B., and Page, R.C. (1990). Participation of
C1q and its receptor in adherence of human diploid fibroblast. J.Southern Blot Analysis
Immunol. 145, 2520–2526.Human genomic DNA was isolated from whole blood using DNAZOL
Reagent according to the directions of the manufacturer. For each Brown, E.J. (1986). The role of extracellular matrix proteins in the
control of phagocytosis. J. Leukoc. Biol. 39, 579–591.digest, 10 mg of DNA was restricted with either BamHI, EcoRI,
HindIII, or PstI and then separated by electrophoresis on a 0.7% Brown, E., Hooper, L., Ho, T., and Gresham, H. (1990). Integrin-
agarose gel in 0.53 TBE. The DNA was fractionated, transferred associated protein: a 50-kD plasma membrane antigen physically
overnight in 103 SSPE to Maximum Strength Nytran (Schleicher & and functionally associated with integrins. J. Cell Biol. 111, 2785–
Schuell), and immobilized using a Stratalinker UV cross-linker (Stra- 2794.
tagene). The clone 15 insert was used as the template to make a
Chroneos, Z., and Shepherd, V.L. (1995). Differential regulation of32P-labeled probe generated by the random priming method using
the mannose and SP-A receptors on macrophages. Am. J. Physiol.the RadPrime DNA labeling system. Hybridization of the probe was
Lung Cell. Mol. Physiol. 269, L721–L726.carried out for 16–20 hr at 428C in 50% formamide, 63 SSPE, 53
Daha, M.R., Miltenburg, A.M.M., Hiemstra, P.S., Klar-Mohamad, N.,Denhardt’s reagent, 0.5% SDS, and 0.1 mg/ml herring sperm DNA.
Van Es, L.A., and Van Hinsbergh, V.W.M. (1988). The complementWashing was done as follows: twice in 73 SSPE, 0.5% SDS for 15
subcomponent C1q mediates binding of immune complexes andmin each at room temperature, twice in 13 SSPE, 0.1% SDS for 15
aggregates to endothelial cells in vitro. Eur. J. Immunol. 18, 783–787.min each at 378C, and then finally once for 30 min at 558C in 0.13
SSPE, 0.5% SDS. The membrane was wrapped in plastic wrap and Daha, M.R., Klar, N., Hoekzema, R., and van Es, L.A. (1990). En-
exposed to autoradiographic film for 2 days at 2708C. hanced Ig production by human peripheral lymphocytes induced
by aggregated C1q. J. Immunol. 144, 1227–1232.
Northern Blot Analysis Dedhar, S. (1994). Novel functions for calreticulin: interaction with
Messenger RNA was isolated from U937 and CEM cells using the integrins and modulation of gene expression. Trends Biochem. Sci.
Micro-FastTrack mRNA isolation kit (Invitrogen, San Diego, CA). We 19, 269–271.
separated 1 mg of each RNA in each of two lanes on a denaturing
Drickamer, K. (1988). Two distinct classes of carbohydrate-recogni-1% agarose gel containing formaldehyde. The RNA was transferred
tion domains in animal lectins. J. Biol. Chem. 263, 9557–9560.overnight in 203 SSPE to Maximum Strength Nytran and UV cross-
Drickamer, K., Dordal, M.S., and Reynolds, L. (1986). Mannose-linked to the membrane. The blot was then probed as in the Southern
binding proteins isolated from rat liver contain carbohydrate-recog-blot with the clone 15 insert or a probe specific for human GAPDH
nition domains linked to collagenous tails: complete primary struc-(a gift from Dr. Hung Fan, University of California, Irvine). A 0.24–9.5
tures and homology with pulmonary surfactant apoprotein. J. Biol.kb RNA ladder was used as a size marker. After washing twice in
Chem. 261, 6878–6887.63 SSPE, 0.1% SDS for 15 min each at room temperature, twice in
13 SSPE, 0.1% SDS for 15 min at 378C, and once in 13 SSPE, 0.1% Epstein, J., Eichbaum, Q., Sheriff, S., and Ezekowitz, R.A.B. (1996).
SDS for 30 min at 508C, bound probe was detected by autoradiogra- The collectins in innate immunity. Curr. Opin. Immunol. 8, 29–35.
phy for 3 days at room temperature. Ezekowitz, R.A.B. (1991). Ante-antibody immunity. Curr. Biol. 1,
60–62.
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